TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Personalized Medicine for Cancer Market Research Report 2022

Global Personalized Medicine for Cancer Market Research Report 2022

  • Category:Life Sciences
  • Published on : 05 November 2022
  • Pages :86
  • Formats:
  • Report Code:SMR-7477502
OfferClick for best price

Best Price: $2320

Personalized Medicine for Cancer Market Size, Share 2022


Market Analysis and Insights: Global Personalized Medicine for Cancer Market

The global Personalized Medicine for Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicine for Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicine for Cancer market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicine for Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicine for Cancer market.

Global Personalized Medicine for Cancer Scope and Market Size

Personalized Medicine for Cancer market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Personalized Medicine for Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Immunotherapy

Targeted Therapy

Chemotherapy

Hormone Therapy

Others

Segment by Application

Breast Cancer

Blood Cancer

Gastrointestinal Cancer

Prostate Cancer

Skin Cancer

Lung Cancer

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Bayer

GlaxoSmithKline

Novartis

Sanofi

Pfizer

Amgen

Merck

Bristol-Myers Squibb

Ariad Pharmaceuticals (Takeda)

Eli Lilly

Roche

Boehringer Ingelheim

Johnson and Johnson

Teva Pharmaceuticals

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Personalized Medicine for Cancer product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Personalized Medicine for Cancer, with price, sales, revenue, and global market share of Personalized Medicine for Cancer from 2019 to 2022.

Chapter 3, the Personalized Medicine for Cancer competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Personalized Medicine for Cancer breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Personalized Medicine for Cancer market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Personalized Medicine for Cancer.

Chapter 13, 14, and 15, to describe Personalized Medicine for Cancer sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Personalized Medicine for Cancer Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Personalized Medicine for Cancer Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 86 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine for Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunotherapy
1.2.3 Targeted Therapy
1.2.4 Chemotherapy
1.2.5 Hormone Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Personalized Medicine for Cancer Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Blood Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Skin Cancer
1.3.7 Lung Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine for Cancer Market Perspective (2017-2028)
2.2 Personalized Medicine for Cancer Growth Trends by Region
2.2.1 Personalized Medicine for Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Personalized Medicine for Cancer Historic Market Size by Region (2017-2022)
2.2.3 Personalized Medicine for Cancer Forecasted Market Size by Region (2023-2028)
2.3 Personalized Medicine for Cancer Market Dynamics
2.3.1 Personalized Medicine for Cancer Industry Trends
2.3.2 Personalized Medicine for Cancer Market Drivers
2.3.3 Personalized Medicine for Cancer Market Challenges
2.3.4 Personalized Medicine for Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine for Cancer Players by Revenue
3.1.1 Global Top Personalized Medicine for Cancer Players by Revenue (2017-2022)
3.1.2 Global Personalized Medicine for Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Personalized Medicine for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicine for Cancer Revenue
3.4 Global Personalized Medicine for Cancer Market Concentration Ratio
3.4.1 Global Personalized Medicine for Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine for Cancer Revenue in 2021
3.5 Personalized Medicine for Cancer Key Players Head office and Area Served
3.6 Key Players Personalized Medicine for Cancer Product Solution and Service
3.7 Date of Enter into Personalized Medicine for Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine for Cancer Breakdown Data by Type
4.1 Global Personalized Medicine for Cancer Historic Market Size by Type (2017-2022)
4.2 Global Personalized Medicine for Cancer Forecasted Market Size by Type (2023-2028)
5 Personalized Medicine for Cancer Breakdown Data by Application
5.1 Global Personalized Medicine for Cancer Historic Market Size by Application (2017-2022)
5.2 Global Personalized Medicine for Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Personalized Medicine for Cancer Market Size (2017-2028)
6.2 North America Personalized Medicine for Cancer Market Size by Country (2017-2022)
6.3 North America Personalized Medicine for Cancer Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Personalized Medicine for Cancer Market Size (2017-2028)
7.2 Europe Personalized Medicine for Cancer Market Size by Country (2017-2022)
7.3 Europe Personalized Medicine for Cancer Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine for Cancer Market Size (2017-2028)
8.2 Asia-Pacific Personalized Medicine for Cancer Market Size by Country (2017-2022)
8.3 Asia-Pacific Personalized Medicine for Cancer Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Personalized Medicine for Cancer Market Size (2017-2028)
9.2 Latin America Personalized Medicine for Cancer Market Size by Country (2017-2022)
9.3 Latin America Personalized Medicine for Cancer Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine for Cancer Market Size (2017-2028)
10.2 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2017-2022)
10.3 Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Personalized Medicine for Cancer Introduction
11.1.4 Bayer Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.1.5 Bayer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Personalized Medicine for Cancer Introduction
11.2.4 GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Personalized Medicine for Cancer Introduction
11.3.4 Novartis Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Personalized Medicine for Cancer Introduction
11.4.4 Sanofi Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.4.5 Sanofi Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Personalized Medicine for Cancer Introduction
11.5.4 Pfizer Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Personalized Medicine for Cancer Introduction
11.6.4 Amgen Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.6.5 Amgen Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Personalized Medicine for Cancer Introduction
11.7.4 Merck Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.7.5 Merck Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Introduction
11.8.4 Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Ariad Pharmaceuticals (Takeda)
11.9.1 Ariad Pharmaceuticals (Takeda) Company Detail
11.9.2 Ariad Pharmaceuticals (Takeda) Business Overview
11.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Introduction
11.9.4 Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.9.5 Ariad Pharmaceuticals (Takeda) Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Detail
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly Personalized Medicine for Cancer Introduction
11.10.4 Eli Lilly Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.10.5 Eli Lilly Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Personalized Medicine for Cancer Introduction
11.11.4 Roche Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.11.5 Roche Recent Development
11.12 Boehringer Ingelheim
11.12.1 Boehringer Ingelheim Company Detail
11.12.2 Boehringer Ingelheim Business Overview
11.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Introduction
11.12.4 Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.12.5 Boehringer Ingelheim Recent Development
11.13 Johnson and Johnson
11.13.1 Johnson and Johnson Company Detail
11.13.2 Johnson and Johnson Business Overview
11.13.3 Johnson and Johnson Personalized Medicine for Cancer Introduction
11.13.4 Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.13.5 Johnson and Johnson Recent Development
11.14 Teva Pharmaceuticals
11.14.1 Teva Pharmaceuticals Company Detail
11.14.2 Teva Pharmaceuticals Business Overview
11.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Introduction
11.14.4 Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2017-2022)
11.14.5 Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Personalized Medicine for Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Hormone Therapy
Table 6. Key Players of Others
Table 7. Global Personalized Medicine for Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Personalized Medicine for Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Personalized Medicine for Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Personalized Medicine for Cancer Market Share by Region (2017-2022)
Table 11. Global Personalized Medicine for Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Personalized Medicine for Cancer Market Share by Region (2023-2028)
Table 13. Personalized Medicine for Cancer Market Trends
Table 14. Personalized Medicine for Cancer Market Drivers
Table 15. Personalized Medicine for Cancer Market Challenges
Table 16. Personalized Medicine for Cancer Market Restraints
Table 17. Global Personalized Medicine for Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Personalized Medicine for Cancer Market Share by Players (2017-2022)
Table 19. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2021)
Table 20. Ranking of Global Top Personalized Medicine for Cancer Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Personalized Medicine for Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Personalized Medicine for Cancer Product Solution and Service
Table 24. Date of Enter into Personalized Medicine for Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Personalized Medicine for Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Personalized Medicine for Cancer Revenue Market Share by Type (2017-2022)
Table 28. Global Personalized Medicine for Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Personalized Medicine for Cancer Revenue Market Share by Type (2023-2028)
Table 30. Global Personalized Medicine for Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Personalized Medicine for Cancer Revenue Market Share by Application (2017-2022)
Table 32. Global Personalized Medicine for Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Personalized Medicine for Cancer Revenue Market Share by Application (2023-2028)
Table 34. North America Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Personalized Medicine for Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Personalized Medicine for Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 44. Bayer Company Detail
Table 45. Bayer Business Overview
Table 46. Bayer Personalized Medicine for Cancer Product
Table 47. Bayer Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 48. Bayer Recent Development
Table 49. GlaxoSmithKline Company Detail
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Personalized Medicine for Cancer Product
Table 52. GlaxoSmithKline Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 53. GlaxoSmithKline Recent Development
Table 54. Novartis Company Detail
Table 55. Novartis Business Overview
Table 56. Novartis Personalized Medicine for Cancer Product
Table 57. Novartis Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 58. Novartis Recent Development
Table 59. Sanofi Company Detail
Table 60. Sanofi Business Overview
Table 61. Sanofi Personalized Medicine for Cancer Product
Table 62. Sanofi Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 63. Sanofi Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Personalized Medicine for Cancer Product
Table 67. Pfizer Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Amgen Company Detail
Table 70. Amgen Business Overview
Table 71. Amgen Personalized Medicine for Cancer Product
Table 72. Amgen Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Merck Company Detail
Table 75. Merck Business Overview
Table 76. Merck Personalized Medicine for Cancer Product
Table 77. Merck Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 78. Merck Recent Development
Table 79. Bristol-Myers Squibb Company Detail
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Personalized Medicine for Cancer Product
Table 82. Bristol-Myers Squibb Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Ariad Pharmaceuticals (Takeda) Company Detail
Table 85. Ariad Pharmaceuticals (Takeda) Business Overview
Table 86. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product
Table 87. Ariad Pharmaceuticals (Takeda) Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 88. Ariad Pharmaceuticals (Takeda) Recent Development
Table 89. Eli Lilly Company Detail
Table 90. Eli Lilly Business Overview
Table 91. Eli Lilly Personalized Medicine for Cancer Product
Table 92. Eli Lilly Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 93. Eli Lilly Recent Development
Table 94. Roche Company Detail
Table 95. Roche Business Overview
Table 96. Roche Personalized Medicine for CancerProduct
Table 97. Roche Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 98. Roche Recent Development
Table 99. Boehringer Ingelheim Company Detail
Table 100. Boehringer Ingelheim Business Overview
Table 101. Boehringer Ingelheim Personalized Medicine for CancerProduct
Table 102. Boehringer Ingelheim Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Johnson and Johnson Company Detail
Table 105. Johnson and Johnson Business Overview
Table 106. Johnson and Johnson Personalized Medicine for CancerProduct
Table 107. Johnson and Johnson Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 108. Johnson and Johnson Recent Development
Table 109. Teva Pharmaceuticals Company Detail
Table 110. Teva Pharmaceuticals Business Overview
Table 111. Teva Pharmaceuticals Personalized Medicine for CancerProduct
Table 112. Teva Pharmaceuticals Revenue in Personalized Medicine for Cancer Business (2017-2022) & (US$ Million)
Table 113. Teva Pharmaceuticals Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicine for Cancer Market Share by Type: 2021 VS 2028
Figure 2. Immunotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Hormone Therapy Features
Figure 6. Others Features
Figure 7. Global Personalized Medicine for Cancer Market Share by Application in 2021 & 2028
Figure 8. Breast Cancer Case Studies
Figure 9. Blood Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Skin Cancer Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Personalized Medicine for Cancer Report Years Considered
Figure 16. Global Personalized Medicine for Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 17. Global Personalized Medicine for Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Personalized Medicine for Cancer Market Share by Region: 2021 VS 2028
Figure 19. Global Personalized Medicine for Cancer Market Share by Players in 2021
Figure 20. Global Top Personalized Medicine for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine for Cancer as of 2021)
Figure 21. The Top 10 and 5 Players Market Share by Personalized Medicine for Cancer Revenue in 2021
Figure 22. North America Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. North America Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 24. United States Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 28. Germany Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Personalized Medicine for Cancer Market Share by Region (2017-2028)
Figure 36. China Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 44. Mexico Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Personalized Medicine for Cancer Market Share by Country (2017-2028)
Figure 48. Turkey Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Saudi Arabia Personalized Medicine for Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Bayer Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 52. Novartis Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 53. Sanofi Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 54. Pfizer Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 55. Amgen Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 56. Merck Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 58. Ariad Pharmaceuticals (Takeda) Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 59. Eli Lilly Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 62. Johnson and Johnson Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 63. Teva Pharmaceuticals Revenue Growth Rate in Personalized Medicine for Cancer Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount